2020
DOI: 10.1002/ame2.12130
|View full text |Cite
|
Sign up to set email alerts
|

Possible implications of animal models for the assessment of visceral pain

Abstract: Visceral pain is the most common but challenging problem seen in clinical patients. Approximately a quarter to a half of the world population experience visceral pain at least once during their life span, which leads to substantial health care costs. 1 Inflammation, ischemia, or mesenteric stretching or distention of the hollow organs of the thoracic, pelvic, or abdominal cavities stimulate the afferent nociceptors to activate the pain pathways. 2 The activated fibers transmit the nociceptive signals to the sp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 87 publications
(143 reference statements)
0
16
0
Order By: Relevance
“…Giving that changes in inflammatory factors, including TNF‐α, IL‐1β, IL‐6, IL‐10, and iNOS, are a major characteristic of the sepsis model, 45 , 46 we measured the inflammatory cytokines after LPS treatment. We observed changes in inflammatory cytokines at different timepoints after LPS treatment ( S3 ).…”
Section: Resultsmentioning
confidence: 99%
“…Giving that changes in inflammatory factors, including TNF‐α, IL‐1β, IL‐6, IL‐10, and iNOS, are a major characteristic of the sepsis model, 45 , 46 we measured the inflammatory cytokines after LPS treatment. We observed changes in inflammatory cytokines at different timepoints after LPS treatment ( S3 ).…”
Section: Resultsmentioning
confidence: 99%
“…Another limitation of this study would be its translationality to humans [ 56 , 57 ]. Even though no animal model can mimic human visceral pain perfectly, visceral pain models have allowed the study of the pathophysiology of the disease, as well as the efficacy of potential analgesics [ 58 , 59 ]. Moreover, while interspecies differences have been described in BoNT sensitivity [ 60 ], protein engineering can produce BoNTs with improved affinity for human receptors to bypass these discrepancies [ 61 ].…”
Section: Discussionmentioning
confidence: 99%
“…Subsequent treatment with methyllycaconitine reversed the beneficial effects of PNU-282987. Varenicline, a non-selective agonist of α7 nAChRs, improved colonic motility and the cholinergic response in a rat IBS model [111]. Other α7-selective agonists including encenicline and AR-R17779 have shown anti-inflammatory effects in mouse models of colitis and postoperative ileus.…”
Section: Inflammatory Control In the Gut Involves The Vagus Nerve And α7 Nachrsmentioning
confidence: 99%